Conflicts of Interest
No author has a relevant conflict of interest. DTT serves on advisory
boards for Janssen, Amgen, La Roche, Sobi, and Humanigen. HB has stock
ownership in CSL Behring. SH serves on the advisory board for Horizon
Pharma. AOJ serves on the advisory board of Pluton Biosciences. MPL is
an advisory board member for Octapharma, Novartis, Aregenix, and
Shionogi, a consultant for Amgen, Novartis, Shionogi, Dova, Bayer, and
has received research funding from Sysmex, Novartis, and Astra Zeneca.
KES received personal fees from Elsevier and Immune Deficiency
Foundation. SEH has received consultancy fee from Sanofi Pasteur, Lumen,
Novavax, and Merck for work unrelated to this report.